Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease
Adult
Genetic Markers
Male
Chronic Obstructive
Heterozygote
Genotype
Chronic Obstructive Pulmonary Disease
Clinical Sciences
Respiratory System
Medical and Health Sciences
chronic obstructive pulmonary disease
Pulmonary Disease
Pulmonary Disease, Chronic Obstructive
03 medical and health sciences
0302 clinical medicine
Clinical Research
Cardiovascular Medicine and Haematology
80 and over
2.1 Biological and endogenous factors
Humans
Longitudinal Studies
Aetiology
Lung
Aged
Emphysema
Aged, 80 and over
Biomedical and Clinical Sciences
COPDGene Investigators
Whole Genome Sequencing
RNA sequencing
Middle Aged
Survival Analysis
Respiratory Function Tests
3. Good health
meta-analysis
Phenotype
Case-Control Studies
alpha 1-Antitrypsin
Respiratory
alpha-1 antitrypsin
Female
DOI:
10.1164/rccm.202106-1404oc
Publication Date:
2021-11-11T22:41:01Z
AUTHORS (184)
ABSTRACT
Multiple studies have demonstrated an increased risk of chronic obstructive pulmonary disease (COPD) in heterozygous carriers the AAT (alpha-1 antitrypsin) Z allele. However, it is not known if MZ subjects with COPD are phenotypically different from noncarriers (MM genotype) COPD.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (26)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....